Macrophages and therapeutic resistance in cancer

Brian Ruffell, Lisa Coussens

Research output: Contribution to journalArticle

356 Citations (Scopus)

Abstract

How neoplastic cells respond to therapy is not solely dependent on the complexity of the genomic aberrations they harbor but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments. Therefore, therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways identified so far whereby macrophages mediate therapeutic responses.

Original languageEnglish (US)
Pages (from-to)462-472
Number of pages11
JournalCancer Cell
Volume27
Issue number4
DOIs
StatePublished - Apr 13 2015

Fingerprint

Macrophages
Tumor Microenvironment
Neoplasms
Critical Pathways
Therapeutics
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Macrophages and therapeutic resistance in cancer. / Ruffell, Brian; Coussens, Lisa.

In: Cancer Cell, Vol. 27, No. 4, 13.04.2015, p. 462-472.

Research output: Contribution to journalArticle

Ruffell, Brian ; Coussens, Lisa. / Macrophages and therapeutic resistance in cancer. In: Cancer Cell. 2015 ; Vol. 27, No. 4. pp. 462-472.
@article{7ff61815a866400cada288809f256afa,
title = "Macrophages and therapeutic resistance in cancer",
abstract = "How neoplastic cells respond to therapy is not solely dependent on the complexity of the genomic aberrations they harbor but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments. Therefore, therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways identified so far whereby macrophages mediate therapeutic responses.",
author = "Brian Ruffell and Lisa Coussens",
year = "2015",
month = "4",
day = "13",
doi = "10.1016/j.ccell.2015.02.015",
language = "English (US)",
volume = "27",
pages = "462--472",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Macrophages and therapeutic resistance in cancer

AU - Ruffell, Brian

AU - Coussens, Lisa

PY - 2015/4/13

Y1 - 2015/4/13

N2 - How neoplastic cells respond to therapy is not solely dependent on the complexity of the genomic aberrations they harbor but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments. Therefore, therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways identified so far whereby macrophages mediate therapeutic responses.

AB - How neoplastic cells respond to therapy is not solely dependent on the complexity of the genomic aberrations they harbor but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments. Therefore, therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways identified so far whereby macrophages mediate therapeutic responses.

UR - http://www.scopus.com/inward/record.url?scp=84928077532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928077532&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.02.015

DO - 10.1016/j.ccell.2015.02.015

M3 - Article

VL - 27

SP - 462

EP - 472

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 4

ER -